According to Han, chairman of Tianjin Ansai Cell Genetic Engineering Co., Ltd. and director of the National Engineering Research Center for Cell Products, in April 2006, the first mesenchymal stem cell bank in China was established in Binhai, Tianjin, undertaking a number of major projects of stem cell research and development under the National 863 Program. The patented technology of isolation, culture and amplification of umbilical cord mesenchymal stem cells invented by researchers makes it possible to industrialize umbilical cord mesenchymal stem cell guidance technology.
Mesenchymal stem cells extracted from umbilical cord can not only be used as an ideal substitute for bone marrow mesenchymal stem cells, but also be used more widely.
According to reports, only a few countries and regions in the world, such as the United States, Britain, Brazil, Canada and China, have mastered the research and development technology of mesenchymal stem cells. The successful operation of Ansai Company indicates that China has taken the lead in realizing an important breakthrough of umbilical cord mesenchymal stem cells from experimental stage to industrial production.